A new study published in The Lancet Psychiatry revealed that one-third of individuals who survived COVID-19 have long-term neurological symptoms.
The study, published Tuesday, examined the “effects of COVID-19 on brain health.”
It concluded that COVID-19 was “associated with increased risk of neurological and psychiatric outcomes.”
The study’s authors learned that the risk of stroke and dementia was elevated due to a COVID-19 diagnosis.
They also found a connection between COVID-19, anxiety and mood disorders.
According to CNN, this study is the largest of its kind and involved 236,000 COVID-19 patients.
Researchers observed that those with COVID-19 had a 44% increased risk for neurological and psychiatric illness than people recovering from other respiratory conditions like the flu.
Similar studies on COVID-19 and its relationship with neurological disorders have been conducted in the past.
A study titled Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection was published in JAMA Psychiatry in February.
This study evaluated 381 White patients who recovered from COVID-19. Out of this group, 30% were found to have PTSD, while others suffered from anxiety and psychotic disorders.
Another study, published in the Journal Neurology: Clinical Practice in December, revealed that neurological complications could occur even in moderate cases of COVID-19.
A limitation of the Lancet Psychiatry study is its use of routine healthcare data instead of research data, CNN reported.